Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masakazu Amari

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Japanese Journal of Clinical Oncology|November 6, 2009
Capecitabine monotherapy is efficient and safe in all line settings in patients with metastatic and advanced breast cancerMasakazu Amari, Takanori Ishida, Motohiro Takeda, et al.
Cureus|May 6, 2024
Granular Cell Tumor Mimicking Breast Carcinoma: A Report of Two CasesMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
Cureus|March 27, 2024
Granulocyte-Colony Stimulating Factor (G-CSF)-Induced Aortitis: A Case ReportMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
International Journal of Clinical Oncology|March 1, 2008
Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groupsTakanori Ishida, Motohiro Takeda, Akihiko Suzuki, et al.
Cancer Science|September 8, 2011
Correlation between mammographic findings and corresponding histopathology: potential predictors for biological characteristics of breast diseasesKentaro Tamaki, Takanori Ishida, Minoru Miyashita, et al.
Breast (Edinburgh, Scotland)|November 24, 2023
Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapyMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
Japanese Journal of Clinical Oncology|May 9, 2007
Reliability of prognostic factors in breast carcinoma determined by core needle biopsyShin Usami, Takuya Moriya, Masakazu Amari, et al.
Breast Cancer Research and Treatment|October 17, 2024
Impact of extended endocrine therapy for patients with risk factors for late recurrence in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after 5 years of endocrine therapyMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
European Radiology|November 18, 2008
Usefulness of lesion image mapping with multidetector-row helical computed tomography using a dedicated skin marker in breast-conserving surgeryNarumi Harada-Shoji, Takayuki Yamada, Takanori Ishida, et al.
Cancer Science|October 11, 2011
Multidetector row helical computed tomography for invasive ductal carcinoma of the breast: correlation between radiological findings and the corresponding biological characteristics of patientsKentaro Tamaki, Takanori Ishida, Minoru Miyashita, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Japanese Journal of Clinical Oncology|November 6, 2009
Capecitabine monotherapy is efficient and safe in all line settings in patients with metastatic and advanced breast cancerMasakazu Amari, Takanori Ishida, Motohiro Takeda, et al.
Cureus|May 6, 2024
Granular Cell Tumor Mimicking Breast Carcinoma: A Report of Two CasesMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
Cureus|March 27, 2024
Granulocyte-Colony Stimulating Factor (G-CSF)-Induced Aortitis: A Case ReportMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
International Journal of Clinical Oncology|March 1, 2008
Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groupsTakanori Ishida, Motohiro Takeda, Akihiko Suzuki, et al.
Cancer Science|September 8, 2011
Correlation between mammographic findings and corresponding histopathology: potential predictors for biological characteristics of breast diseasesKentaro Tamaki, Takanori Ishida, Minoru Miyashita, et al.
Breast (Edinburgh, Scotland)|November 24, 2023
Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapyMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
Japanese Journal of Clinical Oncology|May 9, 2007
Reliability of prognostic factors in breast carcinoma determined by core needle biopsyShin Usami, Takuya Moriya, Masakazu Amari, et al.
Breast Cancer Research and Treatment|October 17, 2024
Impact of extended endocrine therapy for patients with risk factors for late recurrence in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after 5 years of endocrine therapyMasahiro Ito, Masakazu Amari, Akiko Sato, et al.
European Radiology|November 18, 2008
Usefulness of lesion image mapping with multidetector-row helical computed tomography using a dedicated skin marker in breast-conserving surgeryNarumi Harada-Shoji, Takayuki Yamada, Takanori Ishida, et al.
Cancer Science|October 11, 2011
Multidetector row helical computed tomography for invasive ductal carcinoma of the breast: correlation between radiological findings and the corresponding biological characteristics of patientsKentaro Tamaki, Takanori Ishida, Minoru Miyashita, et al.
Pageof 3